Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Ault & Company is a private diversified holding company founded in 2015 that acquires and operates undervalued businesses and disruptive technologies across multiple sectors. Its public-facing materials emphasize strategic investment and operating platforms rather than drug development, clinical assets, or healthcare services. While the firm has exposure to healthcare and life sciences through certain investments and affiliates, Ault & Company itself does not appear to be a biotech, pharma, or healthcare operating company. It is better characterized as an investment and holding entity led by Milton "Todd" Ault III.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Ault & Company.